RNS Number : 6018R
R&Q Insurance Holdings Ltd
27 October 2023
 

 

R&Q Insurance Holdings Ltd

 

("R&Q" or the "Company")

 

PDMR/Director Shareholding and Total Voting Rights

 

 

27 October 2023

 

R&Q Insurance Holdings Ltd (AIM: RQIH) ("R&Q" or the "Group"), the leading non-life global specialty insurance company focusing on the Program Management ("Accredited") and Legacy Insurance ("R&Q Legacy") businesses, announces that on 23 October 2023, Andrew Pinkes, a PDMR, to fund tax liabilities arising from the vesting of his share award, sold 218,220 Ordinary Shares, which in accordance with his share award agreement, have been purchased by the Company to be held in Treasury.

 

PDMR Dealing

 

Name of Director

Total Restricted Ordinary Shares Vested

Total Ordinary Shares Sold

Total Ordinary Shares Retained

Total R&Q Ordinary Shares now held

% of voting rights

Andrew Pinkes

490,597

218,220

272,377

517,675

0.14%

 

Total Voting Rights

 

As a result of this transaction the total issued share capital will remain 377,395,235 Ordinary Shares. Of which 3,790,917 Ordinary Shares are now held in Treasury. Therefore, the total number of voting rights will be 373,604,318 and may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 



Enquiries to:

 

R&Q Insurance Holdings Ltd


William Spiegel

Tel: 0207 780 5850

Tom Solomon 

Tel: 0207 780 5850

 

Numis Securities Limited (Nominated Advisor and Joint Broker)

Giles Rolls 

Tel: 020 7260 1000

Charles Farquhar 

 

Barclays Bank PLC (Joint Broker)

Andrew Tusa

 

Tel: 020 7260 1000

 

 

Tel: 020 7632 2322

FTI Consulting

Tom Blackwell

 

Tel: 020 3727 1051

 

 

Notes to Editors:

 

About R&Q 

 

R&Q is a global non-life specialty insurance company. We operate two core, highly complementary, businesses: Program Management and Legacy Insurance. Both these businesses are leaders in their respective markets.

 

Our approach is to deploy our origination and underwriting capabilities, alongside our licensed and rated carriers in the US, EU and the UK, to generate attractive fee returns in Program Management and Legacy Insurance.

 

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website: www.rqih.com

                                                               

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

  

 

 

1

Details of the person discharging managerial responsibility / person closely associated

 

 

a)

 

Name

 

Andrew Pinkes  

2

Reason for the notification

 

a)

 

Position/status

 

PDMR (Senior Executive)

 

b)

 

Initial notification/amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

R&Q Insurance Holdings Ltd

 

 

 

b)

 

LEI

 

2138006K1U38QCGLFC94

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 2 pence each of the Company

 

 

Identification code

 

Ordinary share ISIN: BMG7371X1065

 

 

b)

 

Nature of transaction

Sale of 218,220 Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

 

1.   Par value of 2p at Grant

Par value of 2p: £4,308.9

 

 

 

 

 

2    £0.24

 

 

 

Sale of 218,220 shares for a total consideration of £ 52,372.80

 

 

 

 

d)

 

Aggregated information

 

 

Aggregated volume

As above

 

 

Price

 

As above

 

 

e)

 

Date of transaction

 

23 October 2023  

 

 

f)

 

Place of transaction

 

Outside of trading location

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEASEXALNDFFA